Patents by Inventor Lana Dinic

Lana Dinic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antigen Binding Molecules Targeting Thymic Stromal Lymphopoietin (TSLP)
    Publication number: 20250109193
    Abstract: The disclosure provides, in various embodiments, polypeptides (e.g., antibodies and antigen binding fragments thereof) that specifically bind to a thymic stromal lymphopoietin (TSLP) (e.g., a full-length human TSLP). The disclosure also provides, in various embodiments, fusion proteins comprising one or more of the polypeptides, polynucleotides encoding the polypeptides, vectors and host cells suitable for expressing the polypeptides, and methods for treating a TSLP-associated disease or condition.
    Type: Application
    Filed: September 4, 2024
    Publication date: April 3, 2025
    Inventors: Antonios O. Aliprantis, Zachary Kohl Costello, Anthony John Coyle, Kristen Park Hopson, Ryan Terrell Phennicie, Alexis Hiram Ramos, Adam Reid Root, Lana Dinic, Karin Alma Frieda Reif
  • Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)
    Patent number: 12110324
    Abstract: The disclosure provides, in various embodiments, polypeptides (e.g., antibodies and antigen binding fragments thereof) that specifically bind to a thymic stromal lymphopoietin (TSLP) (e.g., a full-length human TSLP). The disclosure also provides, in various embodiments, fusion proteins comprising one or more of the polypeptides, polynucleotides encoding the polypeptides, vectors and host cells suitable for expressing the polypeptides, and methods for treating a TSLP-associated disease or condition.
    Type: Grant
    Filed: July 21, 2023
    Date of Patent: October 8, 2024
    Assignee: Flagship Pioneering Innovations VI, LLC
    Inventors: Antonios O. Aliprantis, Zachary Kohl Costello, Anthony John Coyle, Kristen Park Hopson, Ryan Terrell Phennicie, Alexis Hiram Ramos, Adam Reid Root, Lana Dinic, Karin Alma Frieda Reif
  • Antigen Binding Molecules Targeting Thymic Stromal Lymphopoietin (TSLP)
    Publication number: 20240034780
    Abstract: The disclosure provides, in various embodiments, polypeptides (e.g., antibodies and antigen binding fragments thereof) that specifically bind to a thymic stromal lymphopoietin (TSLP) (e.g., a full-length human TSLP). The disclosure also provides, in various embodiments, fusion proteins comprising one or more of the polypeptides, polynucleotides encoding the polypeptides, vectors and host cells suitable for expressing the polypeptides, and methods for treating a TSLP-associated disease or condition.
    Type: Application
    Filed: July 21, 2023
    Publication date: February 1, 2024
    Inventors: Antonios O. Aliprantis, Zachary Kohl Costello, Anthony John Coyle, Kristen Park Hopson, Ryan Terrell Phennicie, Alexis Hiram Ramos, Adam Reid Root, Lana Dinic, Karin Alma Frieda Reif